Confirmed mpox infections in Brazil surpassed one thousand in 2026, driven by rising autumn notifications concentrated primarily in six states, Agência Brasil reported.
The monitoring panel maintained by the Ministério da Saúde recorded 1,023 confirmed cases, 46 probable cases, 581 suspected cases, and one death by Thursday, November 12. The cumulative total since national notification began reached 15,455 cases, with 19 resulting in death.
Rio de Janeiro leads the state distribution with 390 records, followed closely by São Paulo with 388, Ceará with 61, Minas Gerais with 45, the Distrito Federal with 41, and Santa Catarina with 24. Infection numbers rose sharply in the final months of the year, with 293 cases occurring in October and 227 in November.
UOL said that national figures remain significantly lower than the 10,591 cases and 14 deaths recorded in 2022 during the initial arrival of the disease. However, public health officials identified a shift in viral circulation due to the presence of the 1b strain alongside the previously established clade II, according to reporting by Estadão.
Understanding the 2026 Transmission Metrics
Transmission occurs primarily through direct contact with skin lesions, rashes, body fluids, or contaminated objects, alongside prolonged close contact with respiratory secretions. Ministério da Saúde outlined that most current cases display mild to moderate clinical progression.
The disease concentration mirrors seasonal patterns observed in previous years. Similar surges occurred between August and November 2024, when monthly confirmations ranged from 250 to 340 cases. During the peak outbreak of 2022, infections clustered between July and December, peaking in August with 4,265 registrations.
UOL reported that approximately 45% of patients in the Rio de Janeiro patient cohort live with HIV. Klinger Soares Faico Filho, a professor at Universidade Federal de São Paulo, stated in reporting republished from The Conversation that immunosuppression plays a greater role than viral clade in determining severe disease outcomes.
How Mpox Spreads and How to Prevent It
- Transmission Route: The MPXV virus spreads through skin-to-skin contact with active lesions, body fluids, or contaminated textiles like bedsheets and towels.
- Symptom Recognition: Manifestations commonly feature skin or mucosal lesions, swollen lymph nodes, fever, muscle aches, and fatigue.
- Primary Defense: Hand hygiene, environmental disinfection, and avoiding direct contact with infected individuals remain essential prevention measures.
Ministério da Saúde secured 25,000 vaccine doses through negotiations with the Danish manufacturer via the Pan American Health Organization revolving fund. Deliveries are scheduled to arrive within three weeks to reinforce the national strategic stock.
To maximize coverage amid global manufacturing shortages, authorities issued a technical note authorizing intradermal application. This strategy matches guidelines from the World Health Organization, permitting up to a fivefold expansion of doses administered from existing supply.
When to Seek Medical Evaluation for Symptoms
The two-dose regimen requires a 28-day interval.
UOL reported that the antiviral tecovirimat was distributed during the 2022 outbreak based on animal studies, as there was no way to test it in people due to the eradication of smallpox.
Patients exhibiting active skin lesions, unexplained rashes, or swollen lymph nodes after potential exposure must seek evaluation at designated reference immunization centers rather than standard primary clinics.
References
- Agência Brasil. Ministério da Saúde monitoring panel data on mpox cases in Brazil.
- Governo Federal.
- Estadão.
- UOL VivaBem.
- The Conversation.
